SC
BLPH

Sepio Capital’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Sepio Capital’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-23,800
Closed -$21.4K – 369
2022
Q4 		$21.4K Hold
23,800
– – ﹤0.01% 340
2022
Q3 		$26K Hold
23,800
– – ﹤0.01% 321
2022
Q2 		$29K Buy
+23,800
New +$31.8K ﹤0.01% 332

Other funds holding BLPH

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sepio Capital's BLPH Position: Q1 2023 in Review

Sepio Capital sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q1 2023, closing a stake of 23,800 shares — an estimated $21.4K sold.

Sepio Capital first reported a position in BLPH in Q2 2022 and held it in 3 quarters. The position peaked at $29K in Q2 2022. 19 funds tracked by Wall St. Rank hold BLPH as of Q1 2023.

  • Sepio Capital reported no remaining Bellerophon Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Sepio Capital sold 23,800 Bellerophon Therapeutics, Inc. shares in Q1 2023, an estimated $21.4K.
  • Sepio Capital first reported a position in Bellerophon Therapeutics, Inc. in Q2 2022 and held it in 3 quarters.
  • Sepio Capital's Bellerophon Therapeutics, Inc. position peaked at $29K in Q2 2022.
  • 19 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q1 2023.

Based on Sepio Capital's 13F filing for Q1 2023, filed 10 May 2023.